Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SKIN NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02612168
What this trial is testing

Melanoma Image Analysis Algorithm (MIAA) Validation Study

Who this might be right for
Malignant Melanoma
Skin Analytics Limited 514
Early research (Phase 1)Study completedNCT03150810
What this trial is testing

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
BeiGene 139
Not applicableActive Not RecruitingNCT02889458
What this trial is testing

Hong Kong Breast Cancer Study

Who this might be right for
Breast CancerDuctal Carcinoma In Situ
The University of Hong Kong 7,000
Not applicableStudy completedNCT01097278
What this trial is testing

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
SWOG Cancer Research Network 208
Not applicableStudy completedNCT01361035
What this trial is testing

Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients

Who this might be right for
Cervical CancerBreast CancerColorectal Cancer
Tulane University School of Medicine 168
Early research (Phase 1)Active Not RecruitingNCT06691035
What this trial is testing

Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer

Who this might be right for
Breast Cancer Metastatic Breast CancerHER2-negative Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 18
Early research (Phase 1)Study completedNCT00028535
What this trial is testing

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Endometrial Carcinoma+4 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT03002376
What this trial is testing

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 47
Large-scale testing (Phase 3)UnknownNCT02898376
What this trial is testing

Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer

Who this might be right for
Breast CarcinomaFibrosis
Institut de Cancérologie de Lorraine 142
Early research (Phase 1)WithdrawnNCT02569489
What this trial is testing

Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast Cancer

Who this might be right for
Breast Cancer
HUYABIO International, LLC.
Post-approval studies (Phase 4)Ended earlyNCT00604968
What this trial is testing

Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 25
Large-scale testing (Phase 3)Ended earlyNCT03326674
What this trial is testing

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 685
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Large-scale testing (Phase 3)Study completedNCT05761418
What this trial is testing

Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy

Who this might be right for
Myoma;Uterus
Beni-Suef University 90
Not applicableUnknownNCT04045392
What this trial is testing

Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients

Who this might be right for
Breast CancerObesity
Gangnam Severance Hospital 78
Large-scale testing (Phase 3)UnknownNCT05637671
What this trial is testing

Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms

Who this might be right for
Vasomotor Symptoms
Cairo University 146
Testing effectiveness (Phase 2)Ended earlyNCT00880009
What this trial is testing

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 16
Testing effectiveness (Phase 2)Study completedNCT02339532
What this trial is testing

Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status

Who this might be right for
Breast Cancer
UNICANCER 86
Not applicableEnded earlyNCT00899132
What this trial is testing

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Who this might be right for
Non-melanomatous Skin CancerPancreatic CancerSmall Intestine Cancer+1 more
Case Comprehensive Cancer Center 180
Not applicableLooking for participantsNCT05057598
What this trial is testing

DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 50,000
Next Page